v3.25.4
SCHEDULE OF NUMBER OF OPTIONS GRANTED (Parenthetical) (Details) - USD ($)
 6 Months Ended 12 Months Ended
Aug. 01, 2025
Jan. 31, 2026
Jul. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Risk free interest rate     4.10%
Dividend yield   0.00% 0.00%
Stock Option Plan [Member]      
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]      
Number of options granted 37,700 37,700 [1]  
Weighted average exercise price, granted $ 12.50 $ 12.50 [1]  
Number of options issued $ 218,784    
Expected volatility   116.00%  
Expected term   5 years  
Risk free interest rate   3.98%  
Dividend yield   0.00%  
Exercise price   $ 7.50  
[1] On August 1, 2025, the Company granted 37,700 stock options to employees and members of the scientific advisory board at an exercise price of $12.50 per share. All options vest quarterly over two years. The options expire on August 1, 2030. The grant-date fair value of the award was $218,784. The fair value of options granted during the six-month period ended January 31, 2026 was estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions: expected volatility of 116%, expected term of 5.0 years, risk-free interest rate of 3.98%, dividend yield of 0%, and a stock price of $7.50 on the grant date.